Dataset Information

Copy number analysis of the murine platelet proteome spanning the complete abundance range.

ABSTRACT: Data from ProteomeXchange, PXD ID: PXD000747. Experiment: EXQ4_MaZe_SA_P4, file: folder summary. Published as part of Mol Cell Proteomics. 2014 Dec;13(12):3435-45 . From the Abstract: {{i}} ... Using recent technological advances, we here characterized the proteome of murine platelets, key actors in mediating hemostasis and thrombosis ... {{/i}}

INSTRUMENT(S): Instrument

ORGANISM(S): Mus_musculus_viruses, Mouse

DISEASE(S): Not Available

SUBMITTER: Zeiler M, et al.

PROVIDER: GPM32320017734 | GPMDB |

REPOSITORIES: GPMDB

ACCESS DATA

Publications

Copy number analysis of the murine platelet proteome spanning the complete abundance range.

Zeiler Marlis M Moser Markus M Mann Matthias M

Molecular & cellular proteomics : MCP 20140909 12

Knowledge of the identity and quantity of expressed proteins of a cell type is a prerequisite for a complete understanding of its molecular functions. Mass-spectrometry-based proteomics has allowed the identification of the entire protein complement of yeast and the close-to-complete set of proteins expressed in mammalian cell lines. Using recent technological advances, we here characterized the proteome of murine platelets, key actors in mediating hemostasis and thrombosis. We accurately measur ...[more]

PMID: 25205226

Similar Datasets

Project description:Hepatocellular carcinoma (HCC) is a malignant tumor with a high fatality rate, characterized by a poor prognosis and a low 5-year survival rate. Although significant progress has been made in immunotherapy and targeted therapy for HCC in recent years, the overall survival benefits for patients remain very limited. Therefore, the continuous development of new targets and the screening of specific therapeutic drugs are of great significance for further developing precise treatment methods, exploring more effective combination therapies, overcoming drug resistance. In our preliminary work 272 bioactive compounds have been isolated and identified from edible and medicinal traditional Chinese medicines including Lonicera japonica, Cistanche deserticola and Artemisia capillaris. Through systematic screening, we discovered that 16'-decarbomethoxydihydrovoacamine (16'-DEC), which derived from Tabernaemontana corymbosa, can significantly inhibit hepatoma cell viability and migratory capacity. Furthermore, 16'-DEC can act in combination with lenvatinib, an approved targeted drug for HCC, to further inhibit the proliferation of hepatoma cells in vitro and in vivo. Through transcriptome sequencing, we found that 16'-DEC significantly upregulated the autophagy-related signaling pathway. Mechanism studies have validated that 16'-DEC does induce autophagy in hepatoma cells, and blocking autophagy can significantly reverse the anti-tumor activity of 16'-DEC. Furthermore, we found that 16'-DEC inhibited the activation of the mTOR signaling pathway, and molecular docking experiments indicated that 16'-DEC had a high affinity for the mTOR protein. Biochemical kinase assays confirmed 16'-DEC as a direct mTOR inhibitor, suppressing its kinase activity with an IC50 0.83 μM in cell-free systems. Taken together, these results demenstated that 16’-DEC inhibited hepatocellular carcinoma through inducing autophagy by targeting the mTOR pathway, which make it a potential therapeutic agent for HCC.

Dataset Information

Copy number analysis of the murine platelet proteome spanning the complete abundance range.

Publications

Copy number analysis of the murine platelet proteome spanning the complete abundance range.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets